Literature DB >> 11755471

Detection of p53 gene mutations by single strand conformational polymorphism (SSCP) in human acute myeloid leukemia-derived cell lines.

Diana S Fleckenstein1, Cord C Uphoff, Hans G Drexler, Hilmar Quentmeier.   

Abstract

We have identified new mutations in the p53 gene in 3/11 growth factor-independent and in 2/8 growth factor-dependent human acute myeloid leukemia (AML)-derived cell lines by single-strand conformational polymorphism (SSCP) and sequencing analysis. MEG-01 had a triplet deletion at codon 304; F-36P, NB-4 and MV4-11 showed point mutations at codon 344. F-36P had a second point mutation at codon 270 and NB-4 additionally at codon 319. M-MOK had a nucleotide substitution at codon 191. The frequency of p53 mutations in the cytokine-independent cell lines was comparable to that in the cytokine-dependent lines. These results suggest that loss of Wild type (wt) p53 is not the decisive event causing tumor cells to proliferate in vitro without externally added growth factors.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11755471     DOI: 10.1016/s0145-2126(01)00107-2

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


  10 in total

1.  MDM2 antagonists induce p53-dependent apoptosis in AML: implications for leukemia therapy.

Authors:  Kensuke Kojima; Marina Konopleva; Ismael J Samudio; Masato Shikami; Maria Cabreira-Hansen; Teresa McQueen; Vivian Ruvolo; Twee Tsao; Zhihong Zeng; Lyubomir T Vassilev; Michael Andreeff
Journal:  Blood       Date:  2005-07-12       Impact factor: 22.113

2.  The novel Chk1 inhibitor MK-8776 sensitizes human leukemia cells to HDAC inhibitors by targeting the intra-S checkpoint and DNA replication and repair.

Authors:  Yun Dai; Shuang Chen; Maciej Kmieciak; Liang Zhou; Hui Lin; Xin-Yan Pei; Steven Grant
Journal:  Mol Cancer Ther       Date:  2013-03-27       Impact factor: 6.261

3.  MicroRNAs involvement in fludarabine refractory chronic lymphocytic leukemia.

Authors:  Manuela Ferracin; Barbara Zagatti; Lara Rizzotto; Francesco Cavazzini; Angelo Veronese; Maria Ciccone; Elena Saccenti; Laura Lupini; Andrea Grilli; Cristiano De Angeli; Massimo Negrini; Antonio Cuneo
Journal:  Mol Cancer       Date:  2010-05-26       Impact factor: 27.401

4.  Molecular basis of p53 functional inactivation by the leukemic protein MLL-ELL.

Authors:  Dmitri Wiederschain; Hidehiko Kawai; JiJie Gu; Ali Shilatifard; Zhi-Min Yuan
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

5.  Sulfonoquinovosyl diacylglyceride selectively targets acute lymphoblastic leukemia cells and exerts potent anti-leukemic effects in vivo.

Authors:  Chetan Kumar Jain; Bhola Shankar Pradhan; Sukdeb Banerjee; Nirup Bikash Mondal; Subeer S Majumder; Madhumita Bhattacharyya; Saikat Chakrabarti; Susanta Roychoudhury; Hemanta Kumar Majumder
Journal:  Sci Rep       Date:  2015-07-20       Impact factor: 4.379

6.  Discovery of highly potent p53-MDM2 antagonists and structural basis for anti-acute myeloid leukemia activities.

Authors:  Yijun Huang; Siglinde Wolf; Barbara Beck; Lisa-Maria Köhler; Kareem Khoury; Grzegorz M Popowicz; Sayed K Goda; Marion Subklewe; Aleksandra Twarda; Tad A Holak; Alexander Dömling
Journal:  ACS Chem Biol       Date:  2014-01-17       Impact factor: 5.100

7.  Aberrantly reduced expression of miR-342-5p contributes to CCND1-associated chronic myeloid leukemia progression and imatinib resistance.

Authors:  Yi-Ying Wu; Hsing-Fan Lai; Tzu-Chuan Huang; Yu-Guang Chen; Ren-Hua Ye; Ping-Ying Chang; Shiue-Wei Lai; Yeu-Chin Chen; Cho-Hao Lee; Wei-Nung Liu; Ming-Shen Dai; Jia-Hong Chen; Ching-Liang Ho; Yi-Lin Chiu
Journal:  Cell Death Dis       Date:  2021-10-05       Impact factor: 8.469

8.  Camptothecin and khat (Catha edulis Forsk.) induced distinct cell death phenotypes involving modulation of c-FLIPL, Mcl-1, procaspase-8 and mitochondrial function in acute myeloid leukemia cell lines.

Authors:  Therese Bredholt; Elizabeth Ao Dimba; Hanne R Hagland; Line Wergeland; Jørn Skavland; Kjell O Fossan; Karl J Tronstad; Anne C Johannessen; Olav K Vintermyr; Bjørn T Gjertsen
Journal:  Mol Cancer       Date:  2009-11-13       Impact factor: 27.401

9.  Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells.

Authors:  Line Wergeland; Gry Sjøholt; Ingvild Haaland; Randi Hovland; Øystein Bruserud; Bjørn Tore Gjertsen
Journal:  Mol Cancer       Date:  2007-05-11       Impact factor: 27.401

10.  Sensitivity of Acute Myelocytic Leukemia Cells to the Dienone Compound VLX1570 Is Associated with Inhibition of the Ubiquitin-Proteasome System.

Authors:  Karthik Selvaraju; Kourosh Lotfi; Johannes Gubat; Maria Miquel; Amanda Nilsson; Julia Hill; Lasse D Jensen; Stig Linder; Pádraig D'Arcy
Journal:  Biomolecules       Date:  2021-09-10
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.